Mepacrine antagonises tumour cell growth induced by natural polyamines

Anticancer Research

Volumn 28, Issue 5 A, 2008, Pages 2765-2768

  Rossi, Tiziana ^a   Coppi, Andrea ^a   Bruni, Elisa ^a   Ruberto, Antonio ^a   Stefania, Giudice ^a   Baggio, Giosué ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Cell proliferation; MCF 7; Mepacrine; Polyamines; Vero

Indexed keywords

MEPACRINE; PROTEIN P21; PUTRESCINE; SPERMIDINE; SPERMINE;

ARTICLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; GROWTH INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; VERO CELL; WESTERN BLOTTING;

ANIMALS; ANTINEOPLASTIC AGENTS; BIOGENIC POLYAMINES; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; PUTRESCINE; QUINACRINE; SPERMIDINE; SPERMINE; VERO CELLS;

EID: 55749092795     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Pegg AE and McCann PP: Polyamine metabolism and function. Am J of Physiol 245: 212-221, 1982.
2. 1-acetyltransferase activity, polyamine pool depletion, and growth inhibition in human melanoma cell lines. Cancer Res 51: 3715-3720, 1991.
3. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and a target for chemotherapy. Cancer Res 48: 759-774, 1988.
4. Manni A: Polyamine involvement in breast cancer phenotype. In Vivo 16: 493-500, 2002.
5. Kendra KL and Katzenellenbogen BS: An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone receptor levels by estrogen and antiestrogen. J Steroid Biochem 28: 123-128, 1987.
6. Nakadate T, Yamamoto S, Ishii M and Kato R: Inhibition of 12-O-tetradecanoylphorbol-13-acetate-induced epidermal ornithine decarboxylase activity by phospholipase A2 inhibitors and lipoxygenase inhibitor. Cancer Research 42: 2841-2845, 1982.
7. Castelli M, Baggio G, Ruberto AI, Tampieri A, Rossi T, Bossa MR and Galatulas I: Influence of antimalarials chloroquine, quinine, primaquine, and mepacrine on the evolution of Ehrlich ascites tumour. Anticancer Res 16: 1-3, 1996.
8. Wang W, Ho WC, Dicker DT, MacKinnon C, Winkler JD, Marmorstein R and el Deiry WS: Acridine derivatives activate p53 and induce tumour cell death through Bax. Cancer Biol Ther 4: 893-898, 2005.
9. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Meth 65: 55-63, 1983.
10. Rossi T, Coppi A, Bruni E, Sgobba M, Degliesposti G and Rastelli G: In vitro effects of Plasmodium falciparum dihydrofolate reductase inhibitors on normal and cancer cell proliferation. Chem Med Chem 2: 1-4, 2007.
11. 1-acetyltransferase activity increases susceptibility to skin carcinogenesis. Carcinogenesis 28: 2404-2411,2007.
12. Gilmour SK: Polyamines and nonmelanoma skin cancer. Toxicol Appl Pharmacol 224: 249-56, 2007.
13. Kramer DL, Diegelman P, Jell J, Vujcic S, Merali S and Porter CW: Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences. J Biol Chem 283: 4241-4251, 2008.
14. Pegg AE: Recent advances in the biochemistry of polyamines in eukaryotes. Biochem J 234: 249-262, 1986.
15. Wei G, De Feo K, Hayes CS, Woster PM, Mandik Nayak L and Gilmour SK: Elevated ornithine decarboxylase levels activate ataxia telangiectasia mutated-DNA damage signaling in normal keratinocytes. Cancer Res 68: 2214-2222, 2008.
16. Deng W, Jiang X, Mei Y, Sun J, Ma R, Liu X, Sun H, Tian H and Sun X: Role of ornithine decarboxylase in breast cancer. Acta Biochim Biophys Sin 40: 235-243, 2008.
17. Al Moutaery AR and Tariq M: Effect of quinacrine, a phospholipase A2 inhibitor on stress and chemically induced gastroduodenal ulcers. Digestion 58: 129-137, 1997.
18. Tsukahara Y, Morisaki T, Horita Y, Torisu M and Tanaka M: Phospholipase A2 mediates nitric oxide production by alveolar macrophages and acute lung injury in pancreatitis. Ann Surg 229: 385-392, 1999.
19. Gurova KV, Hill JE, Guo C, Prokvolit A, Burdelya LG, Samoylova E, Khodyakova AV, Ganapathi R, Ganapathi M, Tararova ND, Bosykh D, Lvovskiy D, Webb TR, Stark G and Gudkov AV: Small molecules that reactivate p53 in renal cell carcinoma reveal a NF-kappa B-dependent mechanism of p53 suppression in tumors. Proc Natl Acad Sci USA 102: 17448-17453, 2005.
20. Sotelo J, Guevara P, Pineda B and Diaz C: Interstitial quinacrine activates a distinctive immune response effective for tumor immunotherapy. Surgery 136: 700-707, 2004.
21. Gerner EW, Meyskens FL Jr, Goldschmid S, Lance P and Pelot D: Rationale for, and design of, a clinical trial targeting polyamine metabolism for colon cancer chemoprevention. Amino Acids 33: 189-195, 2007.
22. Petros LM, Graminski GF, Robinson S, Burns MR, Kisiel N, Gesteland RF, Atkins JF, Kramer DL, Howard MT and Weeks RS: Polyamine analogs with xylene rings induce antizyme frameshifting, reduce ornithine decarboxylase activity, and deplete cellular polyamines. J Biochem 140: 657-666, 2006.
23. Wallace HM and Niiranen K: Polyamine analogues - an update. Amino Acids 33: 261-265, 2007.
24. Beauchemin R, N'soukpoe Kossi CN, Thomas TJ, Thomas T, Carpentier R and Tajmir Riahi HA: Polyamine analogues bind human serum albumin. Biomacromolecules 8: 3177-3183, 2007.
25. Nair SK, Verma A, Thomas TJ, Chou TC, Gallo MA, Shirahata A and Thomas T: Synergistic apoptosis of MCF-7 breast cancer cells by 2-methoxyestradiol and bis(ethyl)norspermine. Cancer Lett 250: 311-322, 2007.